Literature DB >> 7354059

Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. Identity with the chylomicron remnant transport process.

B C Sherrill, T L Innerarity, R W Mahley.   

Abstract

The canine lipoproteins containing only the E apoprotein (apo-E HDLc), when perfused through a rat liver, display high affinity, receptor-mediated uptake, and saturation kinetics. These data indicate that the hepatic uptake of apo-E HDLc proceeds via a finite number of binding sites. The kinetic values determined for apo-E HDLc binding and uptake during a single-pass perfusion through a rate liver are: Km = 4.99 micrograms of protein . ml-1 and Vmax = 6.42 microgram of protein . g-1 . min-1. On a molar basis, the hepatic extraction of apo-E HDLc is almost equivalent to the high hepatic extraction of a class of lipoproteins that is most avidly removed from systemic circulation--the rat chylomicron remnants. Competition experiments between apo-E HDLc and rat chylomicron remnants indicate that the hepatic uptake mechanism for the two macromolecules is identical. Given that the recognition of apo-E HDLc is mediated by the E apoprotein and that the kinetic uptake properties of chylomicron remnants and apo-E HDLc are almost identical, it is probable that the E apoprotein is the major determinant responsible for hepatic chylomicron remnant recognition.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7354059

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects.

Authors:  D C Rubinsztein; J C Cohen; G M Berger; D R van der Westhuyzen; G A Coetzee; W Gevers
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

Review 2.  Pharmacogenetics of target genes across the warfarin pharmacological pathway.

Authors:  Suman Lal; Srinivasa Rao Jada; Xiaoqiang Xiang; Wan-Teck Lim; Edmund J D Lee; Balram Chowbay
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.

Authors:  Ryan E Temel; Weiqing Tang; Yinyan Ma; Lawrence L Rudel; Mark C Willingham; Yiannis A Ioannou; Joanna P Davies; Lisa-Mari Nilsson; Liqing Yu
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

4.  Regulation of serum apolipoprotein E metabolism: role of chylomicron metabolism.

Authors:  J G DeLamatre; B R Krause; P S Roheim
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

5.  Cellular and subcellular distribution of 125I-labeled very low density lipoproteins in the liver of normal and estrogen-treated rabbits.

Authors:  R V Iozzo; R S Kushwaha; T N Wight; W R Hazzard
Journal:  Am J Pathol       Date:  1982-04       Impact factor: 4.307

6.  Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E.

Authors:  S K Basu; M S Brown; Y K Ho; R J Havel; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

7.  Apolipoprotein E synthesis in human kidney, adrenal gland, and liver.

Authors:  M L Blue; D L Williams; S Zucker; S A Khan; C B Blum
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

8.  Expression of the human apolipoprotein E gene suppresses steroidogenesis in mouse Y1 adrenal cells.

Authors:  M E Reyland; J T Gwynne; P Forgez; M M Prack; D L Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

9.  Immunoreactive apolipoprotein E is a widely distributed cellular protein. Immunohistochemical localization of apolipoprotein E in baboon tissues.

Authors:  C T Lin; Y F Xu; J Y Wu; L Chan
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

10.  Independent regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and chylomicron remnant receptor activities in rat liver.

Authors:  D P Wade; A K Soutar; G F Gibbons
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.